In conclusion, through CRC superenhancer investigations, we identified that the superenhancer activation of oncogene POU5F1B is prevalent in CRC, contributing to the oncogenic gene upregulated expressions. The gene discussed is POU5F1B; the disease is colorectal carcinoma.